Custom Xenograft and Syngeneic Model Development

invivo-magnifyglass.png

"CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease.

Leveraging our industry expertise, CrownBio's global resources help customers answer the most challenging questions about human biology. We begin with the end insight to help you achieve your goals"

Dr Jean-Pierre Wery
CEO, Crown Bioscience Inc.

Development and establishment of xenograft and syngeneic tumor models in mice, from a novel or mutated cancer cell line, can be a time consuming and highly technical process requiring a state of the art in vivo facility and extensive scientific expertise.

CrownBio offers a comprehensive program for xenograft and syngeneic model establishment. Our highly skilled and trained scientists take your mutated/novel cell lines and establish them in mice. Our staff provides you with the QC and growth kinetics for your new model, so that you may begin studies without delay.

Once your newly developed model has been established in vivo, CrownBio can facilitate the downstream characterization required to take your tumor research to the next stage.

Add-on characterization services include:

  • Preclinical efficacy studies
  • RNAseq
  • WES
  • PK/PD
  • Target validation

Request Special Pricing